Expired OTCs, formula cost Walmart $775,000 in N.J.
This article was originally published in The Tan Sheet
Executive SummaryWalmart agrees to pay $775,000 and revise its practices to comply with New Jersey laws after a judge finds the firm sold expired infant formula and nonprescription drugs. The state court ruling found the N.J. Office of the Attorney General proved four of the eight counts in a 2008 lawsuit, including that Walmart sold items at incorrect prices, the AG said Oct. 19. The remaining counts, for questionable business practices and other violations, are to be decided in a trial in Hudson County. Under the settlement, the firm will pay $500,000 in penalties, reimburse the state $160,000 for legal expenses and $40,000 for investigative costs, and pay $75,000 for a consumer education initiative. The settlement requires Walmart to periodically inspect OTC drugs and infant formula and monitor merchandise price accuracy at New Jersey stores. Walmart admitted no wrongdoing in the settlement that supersedes a 2004 consent order the firm and state made to resolve similar issues
You may also be interested in...
Johnson & Johnson has achieved exceptional growth in recent years, and a raft of new products is set to sustain it further.
Bayer’s drive to lead a new market opportunity in Europe for histology-independent cancer agents like Vitrakvi has been set back by interim decisions from the UK’s NICE and Germany’s IQWiG, but there is a now a clear pathway to follow.
Performance-based managed entry agreements need to be made more effective, but this can only happen if countries relax their stance on confidentiality and share information on MEAs amongst themselves, says a working paper from the OECD.